Agilent Technologies (A) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Feb, 2026Executive summary
Annual meeting scheduled for March 18, 2026, at 8 a.m. Pacific Time in Santa Clara, CA.
Pre-registration by March 2, 2026, is required to attend the meeting.
Proxy materials and annual report are available online, with options for electronic or paper delivery.
Voting matters and shareholder proposals
Election of four directors for a three-year term: Judy Gawlik Brown, Sue H. Rataj, George A. Scangos, Ph.D., and Dow R. Wilson.
Advisory vote on executive compensation for named executive officers.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm.
Approval of an amendment to declassify the Board of Directors over a three-year period.
Board recommends voting FOR all nominees and proposals.
Board of directors and corporate governance
Proposal to declassify the Board of Directors, transitioning to annual elections over three years.
Latest events from Agilent Technologies
- Q1 FY26 revenue rose 7% to $1.80B, non-GAAP EPS up 4%, and FY26 guidance was raised.A
Q1 20263 Mar 2026 - Strong growth, innovation, and disciplined strategy support positive outlook for the year.A
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Board seeks approval for director elections, pay, auditor, and Board declassification amid strong governance.A
Proxy Filing6 Feb 2026 - Q2 met expectations, but slower recovery and China headwinds led to a guidance cut.A
Jefferies Global Healthcare Conference31 Jan 2026 - Annual meeting to elect directors, approve pay, ratify auditor, and declassify the Board.A
Proxy Filing23 Jan 2026 - Q3 revenue beat guidance, net income surged, and full-year outlook was raised amid market challenges.A
Q3 202423 Jan 2026 - FY26 targets 4–6% core growth, margin gains, and $7.3B–$7.4B revenue via Ignite and innovation.A
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Q4 non-GAAP EPS up 6% to $1.46; FY25 revenue and EPS growth expected.A
Q4 202412 Jan 2026 - Ignite strategy drives 5%-7% growth, margin expansion, and leadership in high-growth markets.A
Investor Day 202411 Jan 2026